MindRank AI: MindRank Begins IND-enabling Studies of its fir

HANGZHOU, China, Jan. 18, 2022 /PRNewswire/ -- MindRank AI, an artificial intelligence (AI) driven biotech company, today announced that the company has nominated a preclinical candidate (PCC)

Related Keywords

China , Hangzhou , Zhejiang , Zhangming Niu , Months After Program Initiation , After Program , Mindrank , Egins , Nabling , Studies , First , Esigned , Drug , Months , After , Program , Initiation ,